Hasil Filter

4

Total database: 17430
Struktur (SMILES)
0 (0%)
Target
4 (100.0%)
Genomik
0 (0%)
Referensi
4 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (4)

Ansuvimab Approved DB16385
biotech | CAS: 2375952-29-5

Infection with pathogenic filoviruses, such as _Zaire ebolavirus_ (Ebola virus, EBOV), can cause severe hemorrhagic fever in humans, resulting in frequent outbreaks with case fatality rates as high as 90%.[A225933, A225938] Virtually all steps of the EBOV lif…

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Infective AgentsAntibodies +13
Target Protein:
Envelope glycoprotein
Waktu ParuhThe half-life of an…
Vol. DistribusiThe steady-state vo…
KlirensThe clearance of an…
Genetik -
Atoltivimab Approved DB15898
biotech | CAS: 2135632-29-8

Ebola virus (EBOV) remains an important human pathogen within the _Ebolavirus_ genus, having been responsible for at least 17 known outbreaks with an average case fatality rate of 43.92%.[A221825] Immune therapy using monoclonal antibodies (mAbs) is becoming …

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Infective AgentsAntibodies +10
Target Protein:
Envelope glycoprotein
Waktu ParuhAtoltivimab adminis…
Vol. DistribusiAtoltivimab adminis…
KlirensAtoltivimab adminis…
Genetik -
Maftivimab Approved DB15899
biotech | CAS: 2135632-36-7

Ebola virus (EBOV) remains an important human pathogen within the _Ebolavirus_ genus, having been responsible for at least 17 known outbreaks with an average case fatality rate of 43.92%.[A221825] Immune therapy using monoclonal antibodies (mAbs) is becoming …

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Infective AgentsAntibodies +10
Target Protein:
Envelope glycoprotein
Waktu ParuhMaftivimab administ…
Vol. DistribusiMaftivimab administ…
KlirensMaftivimab administ…
Genetik -
Odesivimab Approved DB15900
biotech | CAS: 2135632-30-1

Ebola virus (EBOV) remains an important human pathogen within the _Ebolavirus_ genus, having been responsible for at least 17 known outbreaks with an average case fatality rate of 43.92%.[A221825] Immune therapy using monoclonal antibodies (mAbs) is becoming …

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Infective AgentsAntibodies +10
Target Protein:
Envelope glycoprotein
Waktu ParuhOdesivimab administ…
Vol. DistribusiOdesivimab administ…
KlirensOdesivimab administ…
Genetik -